Lessons Learned From Treating Sepsis May Help With COVID-19 Treatment, UF Researchers Suggest
The mortality rate of the COVID-19 pandemic has altered the standard process of drug development, amplifying the need for lifesaving treatment and marking the start of the sprint toward a cure or gold standard treatment. In a commentary published in Lancet Respiratory Medicine, UF researchers and their collaborators are looking to the past for answers […]
Just – Evotec Biologics to Collaborate With Ology Bioservices on Antibodies Against Coronavirus
Evotec SE, a drug discovery alliance and development partnership company focused on innovative product approaches with leading pharmaceutical and biotechnology companies, announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and […]
Algernon Receives Clearance From Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has received a “No Objection” letter from Health Canada to proceed with NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial. The same study protocol is being prepared for submission to the U.S. FDA and Australian regulatory authorities. “The study […]
Working Inside a COVID-19 Research Testing Lab
While you have probably heard of the conception of the high-capacity COVID-19 research lab built within just 10 days by various University of Florida Public Health and Health Professions faculty, staff and students, it is likely you have not been able to get a glimpse of what it is like to work in a COVID-19 […]
COVID-19 Crisis As Catalyst for Telemedicine
The COVID-19 crisis has caused a rapid advance in the use of telemedicine for patients with neurological conditions. In a new Viewpoint article in JAMA Neurology, Michael S. Okun, M.D., chair of the department of neurology in the UF College of Medicine, and co-authors discuss the impact of this change and its potential long-term effect on […]
Can Air Conditioning Spread the Coronavirus? Why Experts Are Concerned About Public Spaces
Federal officials are exploring the role of the upcoming summer season on the spread of the novel coronavirus in the United States, debating experts’ arguments that humidity, temperatures, and direct sunshine won’t have a direct impact on the virality of COVID-19. But a new piece of evidence published in the journal Emerging Infectious Diseases, shared by the Centers for Disease […]
Full Interview: Algernon Pharmaceuticals Receives OK From South Korea for Phase Two Study of Ifenprodil
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joined Steve Darling from Proactive in Vancouver with big news. The company has received approval from the Ministry of Food and Drug Safety in South Korea for a Phase 2 COVID-19 clinical study of their repurposed drug Ifenprodil . Moreau shares with Proactive […]
Everything You Need to Know About the Ventilator Shortage and COVID 19
Building ventilators to help COVID-19 patients could be much easier than we think. Dr. Samsun Lampotang is a professor of anesthesiology and the director of the Center for Safety, Simulation, and Advanced Learning Technologies at the University of Florida. Based on the design, Lampotang helped create 30 years ago, simple “crisis” ventilators that can be built with parts […]
Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has submitted a Clinical Trial Application (CTA) to Health Canada for an NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial. The same study protocol is being prepared for submission to the U.S. FDA and Australian regulatory authorities. The study […]
Biotech Firm Picks Gainesville As It Seeks COVID-19 Vaccine
Noachis Terra Inc., a new biotechnology company that will focus its efforts on the development of a vaccine for COVID-19 announced its headquarters will be located in Gainesville at UF Innovate | The Hub. Interim President Gary Ascani said the company is working on proposals to public and private investors who to help develop a […]